12 September 2017 - Since the 2015-16 report, the number of submissions received across some Category 1 application types varied significantly.
While the number of New Chemical Entity submissions remained constant, the number of Extension of Indication submissions increased noticeably and the number of generic medicine submissions greatly decreased.
All Category 1 submissions processed in 2016-17 were within the legislated 255 working day timeframe and, on average, were decided in 220 working days or less.